Direxion Daily BRKB Bull 2X ETFBRKU

The launch of the Direxion Daily BRKB Bull 2X ETF (BRKU) on Nasdaq in July 2026 was less a market debut and more a filing event-an exchange tick list entry for a fund that promises to double the daily return of Berkshire Hathaway B shares without the trouble of margin calls or option expiry risk. The ETF lands on the tape with the same fanfare as a minor stock split: a quiet mechanical adjustment in a world already awash with concentrated products, each one peddling the idea that the user can outsource alpha while sipping a latte. The novelty here is not the underlying Berkshire shares, which have traded since the last century, but the wrapper’s 2x daily gearing and the 1.15% annual fee that arrives like a subscription service you didn’t explicitly sign up for.

BRKU is a wrapper, not a moat. Its portfolio is a carbon copy of the B shares it tracks, with the added twist that the fund resets its exposure every trading day to deliver twice the daily move of BRK.B. That means the fund’s returns are path-dependent in the extreme: miss a day, and the compounding math can leave you further from the starting line than you thought possible. The issuer’s marketing leans into the Berkshire halo-stable, long-term, shareholder-friendly-while the fund itself is a high-octane, time-decayed bet on a single equity’s intraday mood. It is the financial equivalent of renting a sports car for a grocery run: technically doable, but the bill at the pump will remind you why you walk.

The fund’s existence is logged in SEC EDGAR under BRKU, confirming its legal structure but not its performance promise. The expense ratio of 1.15% is the clearest number in the prospectus, and it is the fee that will compound against you whether Berkshire rises, falls, or naps through the trading session. The FINRA Fund Analyzer provides the AUM, expense, and liquidity data, but it does not vouch for the fund’s ability to beat its stated benchmark over any horizon longer than a single session. Liquidity, as ever, is a function of whoever shows up willing to trade the concentrated claim on a single holding company’s B shares.

The fund’s chart route is live on Nasdaq, where the price action will reflect the daily reset leverage rather than any intrinsic Berkshire story. TradingView users will see the ETF’s price dance to the ticker BRKU, but the chart will not tell you whether the fund’s holdings are trading at a premium or discount to net asset value, nor will it reveal the daily compounding drag of the 1.15% fee. Those details are buried in the fund’s daily holdings disclosure and prospectus, neither of which are highlighted on the trading screen.

What changed today: BRKU’s first full week of trading brings no earnings release, no product launch, no regulatory filing beyond its initial registration. The only concrete development is the ETF’s tick listing and volume feed on Nasdaq, which confirms the instrument exists and can be bought or sold like any other ticker. There is no parsed revenue, profit, or cash figure for BRKU because it is a wrapper whose returns are synthetic, not operational. The SEC EDGAR search confirms the fund’s legal identity but not its future payouts. The FINRA analyser supplies the fee and liquidity numbers but cannot vouch for the fund’s tracking accuracy beyond the daily reset. The Nasdaq page shows the ticker and price, but it cannot tell you whether the fund’s 2x leverage is worth the price of admission over anything beyond a single session.

What remains unproven: whether the fund’s 2x daily reset will deliver the advertised exposure without bleeding investors via fees, slippage, or compounding against a flat or volatile underlying. The issuer’s marketing promises amplified exposure, but the evidence trail-SEC documents, Nasdaq listing, and FINRA analyser-confirms only the structure and fee, not the performance outcome over any horizon longer than a day. The fund’s success is hostage to the daily mood of BRK.B, the willingness of buyers and sellers to trade the concentrated claim, and the relentless nibbling of the 1.15% annual fee. Until a multi-day track record emerges, BRKU is a bet on the issuer’s ability to sell leverage, not on Berkshire Hathaway’s ability to compound wealth.